Palisade Bio, Inc. (PALI) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Palisade Bio, Inc. (PALI) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $359.3M, listed on NASDAQ, employing roughly 8 people, carrying a beta of 1.53 to the broader market. Palisade Bio, Inc. Led by J. D. Finley, public since 2007-03-30.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for PALI as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →